• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

筛查和监测结肠镜检查中发现的偶发性炎症性肠病的患病率及临床特征

Prevalence and Clinical Features of Incidental Inflammatory Bowel Disease Identified During Screening and Surveillance Colonoscopy.

作者信息

Bronze Sergio, Shenoy Shabari, Agrawal Manasi, Polydorides Alexandros D, Colombel Jean-Frédéric, Rodríguez-Lago Iago, Ungaro Ryan C

机构信息

Gastroenterology and Hepatology Department, Unidade Local de Saúde de Santa Maria, Lisbon, Portugal.

Faculdade de Medicina de Lisboa, Lisbon, Portugal.

出版信息

Dig Dis Sci. 2025 Sep 19. doi: 10.1007/s10620-025-09400-5.

DOI:10.1007/s10620-025-09400-5
PMID:40968301
Abstract

BACKGROUND

Inflammatory bowel disease (IBD) can be detected in the absence of clinical symptoms.

AIMS

To determine the prevalence of incidental IBD in patients undergoing screening colonoscopy and to explore its clinical features and long-term outcomes.

METHODS

We conducted a retrospective cohort study that included all asymptomatic adults who underwent colonoscopy for colorectal cancer screening or polyp surveillance between 2009 and 2023 in a large health system. Incidental IBD was defined as endoscopic and histologic findings consistent with the disease in the absence of symptoms. Clinical characteristics and outcomes were collected.

RESULTS

Among 40,573 patients who underwent colonoscopy, 60 were diagnosed with incidental IBD: 40 with Crohn's disease (CD), 10 with ulcerative colitis (UC), and 10 with IBD-unclassified (IBD-U). Mean age at diagnosis was 54.6 years for CD, 52.8 years for UC, and 55.7 years for IBD-U, with an overall female predominance (53%). Most CD patients had ileal involvement (98%) and inflammatory behavior (98%), and 60% of UC patients had extensive disease. After a mean follow-up period of 27.9 ± 34.7 months, 10 (16.7%) patients developed symptoms, and 5 (8.3%) initiated therapy, mostly after symptom onset. No hospitalizations or surgeries were reported.

CONCLUSION

The prevalence of incidental IBD detected during colorectal cancer screening is low (0.15%), with 20% of CD and 20% of UC cases progressing to symptomatic disease. Incidental IBD has a mild disease course with a low likelihood of progression to complications.

摘要

背景

炎症性肠病(IBD)可在无临床症状的情况下被检测到。

目的

确定接受结肠镜筛查的患者中偶发性IBD的患病率,并探讨其临床特征和长期预后。

方法

我们进行了一项回顾性队列研究,纳入了2009年至2023年期间在一个大型医疗系统中因结直肠癌筛查或息肉监测而接受结肠镜检查的所有无症状成年人。偶发性IBD被定义为在无症状情况下内镜和组织学检查结果符合该病。收集了临床特征和预后情况。

结果

在40573例接受结肠镜检查的患者中,60例被诊断为偶发性IBD:40例为克罗恩病(CD),(10)例为溃疡性结肠炎(UC),(10)例为未分类的IBD(IBD-U)。CD诊断时的平均年龄为54.6岁,UC为52.8岁,IBD-U为55.7岁,总体上女性占优势(53%)。大多数CD患者累及回肠(98%)且具有炎症性表现(98%),60%的UC患者患有广泛性疾病。在平均随访27.9±34.7个月后,10例(16.7%)患者出现症状,5例(8.3%)开始治疗,大多在症状出现后。未报告住院或手术情况。

结论

在结直肠癌筛查期间检测到的偶发性IBD患病率较低(0.15%),20%的CD和20%的UC病例进展为有症状疾病。偶发性IBD病程较轻,进展为并发症的可能性较低。

相似文献

1
Prevalence and Clinical Features of Incidental Inflammatory Bowel Disease Identified During Screening and Surveillance Colonoscopy.筛查和监测结肠镜检查中发现的偶发性炎症性肠病的患病率及临床特征
Dig Dis Sci. 2025 Sep 19. doi: 10.1007/s10620-025-09400-5.
2
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
3
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD000279. doi: 10.1002/14651858.CD000279.pub3.
4
Impact of moderate-to-severe ulcerative colitis and Crohn's disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) survey.中重度溃疡性结肠炎和克罗恩病对性活动的影响:来自炎症性肠病经历的沟通需求与特征(CONFIDE)调查的美国和欧洲患者观点
Curr Med Res Opin. 2025 Jul 17:1-14. doi: 10.1080/03007995.2025.2530736.
5
Healthcare resource utilization and production loss in vedolizumab-treated inflammatory bowel disease patients: results from the Swedish prospective multicentre SVEAH study.维多珠单抗治疗的炎症性肠病患者的医疗资源利用和生产损失:瑞典前瞻性多中心SVEAH研究的结果
Therap Adv Gastroenterol. 2025 Jul 17;18:17562848251352023. doi: 10.1177/17562848251352023. eCollection 2025.
6
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2004(2):CD000279. doi: 10.1002/14651858.CD000279.pub2.
7
Patient education interventions for the management of inflammatory bowel disease.炎症性肠病管理的患者教育干预措施。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
8
Vitamin D for the treatment of inflammatory bowel disease.维生素 D 治疗炎症性肠病。
Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD011806. doi: 10.1002/14651858.CD011806.pub2.
9
Helminth therapy (worms) for induction of remission in inflammatory bowel disease.蠕虫疗法(使用蠕虫)诱导炎症性肠病缓解
Cochrane Database Syst Rev. 2014 Jan 20;2014(1):CD009400. doi: 10.1002/14651858.CD009400.pub2.
10
Strategies for detecting colon cancer in patients with inflammatory bowel disease.炎症性肠病患者结肠癌的检测策略。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD000279. doi: 10.1002/14651858.CD000279.pub4.

本文引用的文献

1
Inflammatory bowel disease uncovered in fecal immunochemical test positive patients in a Canadian provincial colon cancer screening program.在加拿大省级结肠癌筛查计划中,粪便免疫化学检测阳性的患者中发现炎症性肠病。
Sci Rep. 2024 Oct 3;14(1):22967. doi: 10.1038/s41598-024-73817-7.
2
Transmural cross-sectional findings and bowel damage assessment in preclinical Crohn's disease: a case-control study.临床前克罗恩病的透壁横截面研究结果及肠道损伤评估:一项病例对照研究
Int J Colorectal Dis. 2024 Jun 14;39(1):92. doi: 10.1007/s00384-024-04660-5.
3
Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease.
系统评价与荟萃分析:炎症性肠病的诊断时间及延迟诊断对临床结局的影响
Aliment Pharmacol Ther. 2023 Mar;57(6):635-652. doi: 10.1111/apt.17370. Epub 2023 Jan 10.
4
Prevalence and Progression of Incidental Terminal Ileitis on Non-diagnostic Colonoscopy: A Systematic Review and Meta-analysis.非诊断性结肠镜检查中偶然末端回肠炎的发生率和进展:系统评价和荟萃分析。
J Crohns Colitis. 2021 Sep 25;15(9):1455-1463. doi: 10.1093/ecco-jcc/jjab030.
5
Pathophysiology of Inflammatory Bowel Diseases.炎症性肠病的病理生理学
N Engl J Med. 2020 Dec 31;383(27):2652-2664. doi: 10.1056/NEJMra2002697.
6
Inflammatory bowel disease in a colorectal cancer screening population: Diagnosis and follow-up.结直肠癌筛查人群中的炎症性肠病:诊断与随访。
Dig Liver Dis. 2021 May;53(5):587-591. doi: 10.1016/j.dld.2020.07.036. Epub 2020 Aug 27.
7
Early Indolent Course of Crohn's Disease in Newly Diagnosed Patients Is Not Rare and Possibly Predictable.初诊克罗恩病患者存在早期惰性病程并不罕见,且可能具有可预测性。
Clin Gastroenterol Hepatol. 2021 Aug;19(8):1564-1572.e5. doi: 10.1016/j.cgh.2020.06.069. Epub 2020 Jul 3.
8
Early microscopic findings in preclinical inflammatory bowel disease.临床前炎症性肠病的早期显微镜发现。
Dig Liver Dis. 2020 Dec;52(12):1467-1472. doi: 10.1016/j.dld.2020.05.052. Epub 2020 Jun 26.
9
Characteristics and Progression of Preclinical Inflammatory Bowel Disease.临床前炎症性肠病的特征和进展。
Clin Gastroenterol Hepatol. 2018 Sep;16(9):1459-1466. doi: 10.1016/j.cgh.2017.11.006. Epub 2017 Nov 11.
10
Ulcerative colitis.溃疡性结肠炎。
Lancet. 2017 Apr 29;389(10080):1756-1770. doi: 10.1016/S0140-6736(16)32126-2. Epub 2016 Dec 1.